3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase NA
1
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Neoplasms
3
Febrile Neutropenia
3
Prostatic Neoplasms
2
Neutropenia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Infections
1
Hematologic Neoplasms
1
Early Stage Breast Cancer
1
Cysts
1
Cystectomy
1
Breast Neoplasms
1
Interventions
Zoledronic Acid
14
Leuprolide
9
bicalutamide
6
Triptorelin Pamoate
6
Goserelin
6
luprolide acetate gel depot
5
enzalutamide
5
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
5
Dutasteride
5
fluciclovine F-18
3
darolutamide
3
Sodium Chloride
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Flutamide
3
Androgen Antagonists
3
Abiraterone Acetate
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
cabazitaxel
2
Propofol
2
Prednisolone
2
Lidocaine
2
Gonadotropin-Releasing Hormone
2
Finasteride
2
Dexamethasone
2
Desflurane
2
Ciprofloxacin
2
testosterone 17 beta-cypionate
1
semaglutide
1
polyethylene glycol 3350
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Prostatic Neoplasms
×
Ciprofloxacin
×
Clear all
NCT03228108
2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4
Completed
1,538 enrolled
NCT01649635
2016-07-06
PROSPECTA
Sanofi
Phase 4
Completed
45 enrolled